Investors Capital Advisory Services’s Microbot Medical MBOT Stock Holding History

Investors Capital Advisory Services’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-24	Closed	-$39K	–	752
2015 Q1	$39K	Sell	24 -1	-4%	-$1.79K	0.01%	709
2014 Q4	$37K	Sell	25 -7	-22%	-$12.7K	0.01%	694
2014 Q3	$65K	Sell	32 -3	-9%	-$7.91K	0.01%	653
2014 Q2	$115K	Sell	35 -5	-13%	-$11.5K	0.02%	634
2014 Q1	$87K	Buy	40 +19	+90%	+$45.4K	0.02%	617
2013 Q4	$41K	Sell	21 -1	-5%	-$2.12K	0.01%	621
2013 Q3	$60K	Buy	22 +2	+10%	+$5.42K	0.02%	561
2013 Q2	$52K	Buy	+20	New	+$56.4K	0.02%	522

Other funds holding MBOT

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Investors Capital Advisory Services's MBOT Position: Q2 2015 in Review

Investors Capital Advisory Services sold out of Microbot Medical (MBOT) in Q2 2015, closing a stake of 24 shares — an estimated $39K sold.

Investors Capital Advisory Services first reported a position in MBOT in Q2 2013 and held it in 8 quarters. The position peaked at $115K in Q2 2014. 30 funds tracked by Wall St. Rank hold MBOT as of Q2 2015.

Investors Capital Advisory Services reported no remaining Microbot Medical position as of Q2 2015 after selling out during the quarter.
Investors Capital Advisory Services sold 24 Microbot Medical shares in Q2 2015, an estimated $39K.
Investors Capital Advisory Services first reported a position in Microbot Medical in Q2 2013 and held it in 8 quarters.
Investors Capital Advisory Services's Microbot Medical position peaked at $115K in Q2 2014.
30 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2015.

Based on Investors Capital Advisory Services's 13F filing for Q2 2015, filed 3 Aug 2015.